Weekly Top Ten News Stories – 14 August 2020

FNArena’s Corporate Results Monitor is keeping track of company results this month:https://www.fnarena.com/index.php/reporting_season/In this week’s Weekly Insights:-August 2020: Nothing Like The Past-M

Presidential nominee Joe Biden has reiterated his objection to President Trump's nuclear energy plan.

Michael Gable of Fairmont Equities suggests that after a period of consolidation, Afterpay should now resume its rally.

Peter Switzer of the Switzer Report lists thirteen stocks offering 10-20% upside if the forecasts of leading stock brokers are accurate.

The New Criterion's Tim Boreham highlights ASX-listed biotechs with skin in the vaccine/treatment game.

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

The ASX200 rose a measly 0.5% in July led by materials, technology and consumer staples; the August reporting season may find companies hesitant to provide guidance amid an uncertain outlook

SPONSORED: Investors are rushing into gold stocks as the precious metal continues to hit new highs. The gold price is now above AU$2,000/oz, for the first time ever, and it seems to have plenty more in the tank with forecasters tipping a rise to US$3,000/oz within a year

Has demand for ventilators stemming from the pandemic run its course? The main issue for ResMed in the near term is whether a reduction in ventilator sales will be countered by a recovery in its sleep business.

Weekly Broker Wrap: Banks will find it difficult to portray a true picture of their performance; market not yet pricing in A$ risks for companies with offshore exposure; continued support to childcare to help operators survive the pandemic